ESPR
ESPR

Esperion Therapeutics Inc

NASDAQ · Pharmaceuticals
$3.40
+0.22 (+6.92%)
Analyst Consensus
Strong Buy
14 analysts
Buy 11 79%
Hold 2 14%
Sell 1 7%
Price Target
Analyst Price Target +456.2% upside
Low Target $12.50
Average Target $18.91
High Target $21.23
Current Price $3.40
Current
$3.40
Target
$18.91
$12.50 $18.91 avg $21.23